Dr Thomas Nesselhut studied biology in Göttingen and was granted a diploma in biochemistry, microbiology and chemistry. He received his doctorate in biochemistry and studied medicine in Göttingen. He was scholar at the Max-Planck-Institut for experimental medicine in Göttingen and at the Nuffield Laboratory of Ophthalmology in Oxford, England. He became the head of the laboratory for tumour biology at the department for women’s health in Göttingen, manufacturing of autologous tumor vaccines for active specific immunotherapy.
In 1993, he founded the practice Neßelhut with a focus on oncology in Duderstadt, treatment of patients with immunotherapy.
We use cookies to improve your experience on our site. Learn more.
We use cookies to enhance your browsing experience and enable essential functions on our website. Some cookies are categorised as "Necessary" are automatically stored on your browser as they are crucial for the basic operation of the site - they can no be adjusted using these tools. Additionally, we use third-party cookies to help us analyse your usage of the website. These cookies are stored in your browser only with your prior consent. You have the option to enable or disable some or all of these cookies.